Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in Canada / NCT05645510
Recruiting Observational

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

NCT05645510 · tracked via the Priya Life Science Canada tracker
Sponsor
University of Alberta
Phase
Observational
Started
2022-11-24
Last updated
2026-05-11

Condition(s) studied

CancerTyrosine Kinase MutationBreast CancerMelanomaMultiple MyelomaChronic LeukemiaProstate CancerOvarian CancerColorectal CancerLung Cancer

Study summary

People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: taking chronic targeted anti-cancer agents - Exclusion Criteria: \-

Primary outcome measure(s)

  • Interview — 3 months
    Interview to learn the experiences of people living with incurable cancers

Trial sites (1)

FacilityCityRegionStatus
Edith Pituskin Edmonton Alberta Recruiting

More University of Alberta trials in Canada

Clinical Evaluation of Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis Active, not recruiting
Digital Health Pathway for Children With Medical Complexity Requiring Tracheostomy Recruiting
HIIT in Pediatric Heart Transplant Recipients (MedBIKE™) Recruiting
Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease Recruiting
Trifecta-Lung cfDNA-MMDx Study Recruiting

Other trials for the same condition

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma Recruiting
Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers Recruiting
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors Recruiting
The Young Women's Breast Cancer Study Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05645510 on ClinicalTrials.gov ↗ ← All trials in Canada